After strict review by the professional committee of the US FDA (US Food and Drug Administration) authoritative organization, on May 17, 2022, SyncoZymes (Shanghai) Co., Ltd. officially received the FDA's confirmation letter (AKL): NMN raw material successfully passed NDI (New Dietary Ingredient) approval.

Syncozymes's annual production of 100 tons of coenzyme NMN/NADH/NAD series products will be officially put into production in October this year!

Syncozymes's annual production of 100 tons of coenzyme NMN/NADH/NAD series products will be officially put into production in October this year!

On January 5, 2021, Shangke Biopharmaceutical (Shanghai) Co., Ltd. was awarded the "(S)-1-tert-butoxycarbonyl-3-hydroxypiperidine" Shanghai High-tech Achievement Transformation Project.

The "Global Matchmaking Club" cross-border matchmaking platform is independently developed by ICBC and is open to global enterprises free of charge. Matching activities” and other core functions. Since the platform was launched for more than two months, it has attracted nearly 20,000 enterprises to settle in, covering more than 40 countries and regions, covering more than 30 industries such as food and medicine, energy and chemical industry, and technical equipment. The platform is committed to conforming to the general trend of open and cooperative world economic development, serving the new development pattern with the concept of inclusive finance, and continuously contributing financial positive energy to the building of an open world economy.

On October 14, 2020, the 85th China International Pharmaceutical API/Intermediate/Packaging/Equipment Fair (referred to as API China API) opened at the Nanjing International Expo Center. Shangke Bio and Zhejiang Supor Pharmaceutical Co., Ltd. participated in the 2020 Nanjing API CHINA API Exhibition. Dr. Zhu, General Manager of Shangke Biology, made a special academic report on "NMN's Past, Present and Future" at the exhibition.

In September 2020, Syncozymes's NMN products passed the SELF GRAS (US Safety Index for Evaluation of Food Additives) safety certification. NMN has been dubbed the "elixir" by the public, and its main function is to repair DNA, healthy cells, and relieve various diseases caused by aging.

In August 2020, the "Bio-enzyme Library Development and Green Catalytic Synthesis Application" project of Zhejiang Syncozymespharmaceutical Co., Ltd. passed the preliminary review of the Zhejiang Provincial Key R&D Program of the Zhejiang Provincial Department of Science and Technology.

The recent outbreak of the concept of "longevity medicine" NMN has caused shocks in the capital market. In mid-July, the "Internet celebrity longevity medicine" NMN concept stock became a dark horse in the market. The stocks of related companies have been closed one after another, and a listed company has gained 8 daily limits in 11 days.